IKNA - Ikena Oncology GAAP EPS of -$0.39 misses by $0.25 revenue of $5.45M misses by $14.51M
2023-03-14 07:51:18 ET
- Ikena Oncology press release ( NASDAQ: IKNA ): Q4 GAAP EPS of -$0.39 misses by $0.25 .
- Revenue of $5.45M (-73.0% Y/Y) misses by $14.51M .
- As of December 31, 2022, Ikena had $156.9 million in cash, cash equivalents, and marketable securities, and believes this will be sufficient to meet its operating requirements into 2025.
For further details see:
Ikena Oncology GAAP EPS of -$0.39 misses by $0.25, revenue of $5.45M misses by $14.51M